Clinical Trial Update: Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy [NA]

View source ↗

Summary

Clinical trial assessing tranexamic acid to reduce blood loss and transfusion after periacetabular osteotomy has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Dysplasia of the Hip

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Dysplasia, Congenital Hip | NA | Status: COMPLETED | Results posted: 2022-11-25